Vontobel Holding
RVPH

Vontobel Holding’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Vontobel Holding’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700
Closed -$52.9K – 1142
2024
Q1 		$52.9K Hold
700
– – ﹤0.01% 1051
2023
Q4 		$72.1K Buy
+700
New +$62.8K ﹤0.01% 1056

Other funds holding RVPH

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.19% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vontobel Holding's RVPH Position: Q2 2024 in Review

Vontobel Holding sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2024, closing a stake of 700 shares — an estimated $52.9K sold.

Vontobel Holding first reported a position in RVPH in Q4 2023 and held it in 2 quarters. The position peaked at $72.1K in Q4 2023. 31 funds tracked by Wall St. Rank hold RVPH as of Q2 2024.

  • Vontobel Holding reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2024 after selling out during the quarter.
  • Vontobel Holding sold 700 REVIVA PHARMA HLDGS INC shares in Q2 2024, an estimated $52.9K.
  • Vontobel Holding first reported a position in REVIVA PHARMA HLDGS INC in Q4 2023 and held it in 2 quarters.
  • Vontobel Holding's REVIVA PHARMA HLDGS INC position peaked at $72.1K in Q4 2023.
  • 31 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.